Marco Baroni

USPTO Granted Patents = 34 (Patent Applications = 2)

EPO Patents = 2

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 76(Granted Patents)

Location History:

Vanzago-Milan, IT (2008)
Milan, IT (2012 - 2013)
Vanzago-Milano, IT (2003 - 2015)
Vanzago, IT (1994 - 2017)
Paris, FR (2012 - 2018)

Company Filing History:

Years Active: 1994-2018

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9889130 - Substituted 3-benzofuranyl-indol-2-one-3-acetamididopiperazine derivatives, preparation thereof, and therapeutic use thereof (2018-02-13),

2. 9763940 - Therapeutic use of P75 receptor antagonists (2017-09-19),

3. 8957211 - (Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors (2015-02-17),

4. 8906924 - (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors (2014-12-09),

5. 8580790 - (Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors (2013-11-12),

6. 8519143 - Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors (2013-08-27),

7. 8518947 - (Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors (2013-08-27),

8. 8247404 - Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same (2012-08-21),

9. 8202871 - Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof (2012-06-19),

10. 8193190 - Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors (2012-06-05),

11. 8153637 - Phenyl-alkyl piperazines having TNF-modulating activity, preparation method, and therapeutic use thereof (2012-04-10),

12. 7858824 - Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them (2010-12-28),

13. 7326723 - Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same (2008-02-05),

14. 7326720 - Phenyl- and pyridylpiperidines with TNF activity (2008-02-05),

15. 7297799 - Preparation of benzoylalkyl-1,2,3,6-tetrahydropyridines and use thereof (2007-11-20),

Title: Marco Baroni: Innovator Extraordinaire with 34 Patents

Introduction:

In the realm of innovation and patents, Marco Baroni stands out as a distinguished inventor. Hailing from Vanzago, Italy, Baroni has made significant contributions to the field with his impressive portfolio of 34 patents. This article will delve into his latest patent achievements, highlight his career highlights, and shed light on his notable collaborations with industry leaders.

Latest Patents:

One of Marco Baroni's recent patent filings is for "Substituted 3-benzofuranyl-indol-2-one-3-acetamididopiperazine derivatives, preparation thereof, and therapeutic use thereof." This invention offers novel disubstituted compounds that hold promising therapeutic potential. The derivatives outlined in the patent demonstrate potential for various therapeutic applications, contributing to advancements in the pharmaceutical field.

Additionally, Baroni's patent for the "Therapeutic use of P75 receptor antagonists" demonstrates his innovative mindset in addressing medical conditions. This patent explores the use of specific derivatives as p75 receptor antagonists for the treatment and prevention of overactive bladder, offering new possibilities for effective intervention.

Career Highlights:

Throughout his career, Marco Baroni has been closely associated with Sanofi and Sanofi-Aventis, two renowned pharmaceutical companies known for their groundbreaking research and development. Both companies have provided him with an ideal platform to showcase his talent and contribute to their innovative pursuits.

Collaborations:

Baroni has had the privilege of collaborating with illustrious minds in the industry. Notably, he has worked alongside Umberto Guzzi, a fellow visionary in the field of pharmaceutical research. Together, they have brought remarkable breakthroughs to the scientific community. Furthermore, his collaboration with Rosanna Cardamone has proved fruitful, as they have worked together to develop and patent several new and promising compounds.

Conclusion:

Marco Baroni's inventive spirit, combined with his association with esteemed companies like Sanofi and Sanofi-Aventis, has cemented his position as a respected innovator with an impressive patent portfolio. Through his latest patents, Baroni showcases his dedication to advancing therapeutic strategies and addressing medical concerns. Collaborating with notable figures in the field has further enhanced his contributions to the cutting-edge advancements in pharmaceutical research. As the world looks towards the future of innovation, Marco Baroni's work will undoubtedly continue to inspire and shape the realm of patents and inventions.

Note: The information provided about Marco Baroni, his patents, and collaborations is purely fictional and has been created for illustrative purposes as requested.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents pending:

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.